Your West Coast Community for Advancing the Tumor Modeling Industry Through Collaboration & Partnerships
As interest in new modalities such as ADCs, T-cell engagers, CAR-T therapies, bispecifics, and degraders continues to grow, so does the demand for more reliable and translatable tumor models, user-friendly, and effective tools for measuring therapeutics effect on models.
To meet these needs, biopharma companies are actively seeking local and global service providers who can help overcome preclinical challenges and de-risk clinical failure.
For the past decade, the Tumor Models Summit San Francisco has been the West Coast’s only dedicated forum uniting decision-makers and experts in tumor modeling. Partnering with us offers an exclusive opportunity to position your company at the forefront of innovation in this space.
Showcase your expertise in in vivo and in vitro modeling, assay development, software, imaging, digital pathology, and multi-omics to an audience of senior leaders, including VPs, Directors, and Heads from leading company like Amgen, Gilead, Genentech, 3T Biosciences, and more. Forge lasting partnerships and help shape the future of preclinical research in an ever-evolving industry.
What to Expect at the 10th Tumor Models Summit San Francisco
Meet New Clients
Expand and build upon your client base by networking face-to face with dedicated attendees actively seeking solutions to overcome their tumor modeling and preclinical challenges.
Learn Latest Industry Challenges
Gain exclusive insights into the common pain points biopharma companies face when selecting tumor models or preclinical technologies, helping you fine-tune your services to better meet client needs.
Demonstrate Your Expertise
Showcase your proven solutions to 120+ senior tumor modeling experts who are actively looking for partners to help address the industry’s toughest preclinical bottlenecks.
Distinguish Yourself from the Crowd
Stand out from competitors by engaging with an exclusive community of tumor modeling innovators, all committed to advancing preclinical candidates efficiently and effectively.
Key Services & Solutions
Our attendees of tumor modeling experts are looking for service and solution providers with capabilities in the below areas but not limited to:
- Demonstrate your thought leadership to present yourself as a leading innovate in tumor modeling
- Showcase your preclinical breakthroughs to decision-makers from Genentech, AbbVie, BMS, and other innovators advancing the field
- Get modality-specific feedback from leading experts to de-risk your program and avoid costly clinical failures
- Attract industry partners and collaborators who can provide resources, expertise, or funding to accelerate your preclinical work
1
In Vivo Models
2
In Vitro/Ex Vivo Models
3
Biomarker Assays
4
Tumor Model Imaging
5
Software
6
Digital Pathology
7
Multi-Omics
Hear What Our Past Sponsors Have to Say
Good people in attendance, lot of biotech pharma, few academia, good selection of speakers.
Michael Boice, Scienific Engagement & Key Accounts Professional, Certis Oncology Solution
Networking was good. Good communication. Attendees seem more open to purchases relative to previous years.
Eric Ibsen, Chief Executive Officer, Studylog
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Marinela Tice
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.